Literature DB >> 12813455

Gadd34 functional domains involved in growth suppression and apoptosis.

M Christine Hollander1, Silpa Poola-Kella, Albert J Fornace.   

Abstract

Gadd34 (also known as MyD116) was originally described as a growth arrest and DNA damage-inducible gene. Increased expression of Gadd34 was subsequently found to correlate with apoptosis, and forced overexpression of the protein leads to apoptosis. Gadd34 protein modulates protein phosphatase type 1 activity through both direct binding to the protein, as well as through binding to other proteins that also modulate phosphatase activity. In addition, Gadd34 has a region of homology with the herpes simplex virus type 1 ICP34.5 protein that is involved in the prevention of apoptosis in infected cells. Recently it was reported that a novel rat Gadd34-related gene, PEG-3, was upregulated in transformed cells, and that forced expression of this gene led to increased tumorigenic potential of cells implanted into nude mice and increased angiogenesis of these tumors. We have found, however, that PEG-3 does not exist in normal rat cells, which have a single diploid complement of Gadd34. Sequence analysis of the rat Gadd34 gene and comparison with PEG-3 indicates that PEG-3 is most likely a mutant of Gadd34 that perhaps arose as a result of transformation. This finding suggests that truncated Gadd34 may interfere with normal Gadd34 function in transfected cells. However, human Gadd34 lacking the viral homology domain does not interfere with normal Gadd34-induced apoptosis in cultured cells. This suggests that viral similarity sequences may be required for Gadd34-mediated functions other than apoptosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12813455     DOI: 10.1038/sj.onc.1206567

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  C-terminal region of GADD34 regulates eIF2α dephosphorylation and cell proliferation in CHO-K1 cells.

Authors:  Ryo Otsuka; Nagakatsu Harada; Shouhei Aoki; Kanna Shirai; Kazuchika Nishitsuji; Ayane Nozaki; Adzumi Hatakeyama; Masayuki Shono; Noriko Mizusawa; Katsuhiko Yoshimoto; Yutaka Nakaya; Hiroshi Kitahata; Hiroshi Sakaue
Journal:  Cell Stress Chaperones       Date:  2015-08-30       Impact factor: 3.667

2.  Development of antiproliferative phenylmaleimides that activate the unfolded protein response.

Authors:  Ulrike Muus; Curtis Hose; Wei Yao; Teresa Kosakowska-Cholody; David Farnsworth; Marzena Dyba; George T Lountos; David S Waugh; Anne Monks; Terrence R Burke; Christopher J Michejda
Journal:  Bioorg Med Chem       Date:  2010-04-24       Impact factor: 3.641

3.  Targeting gene expression selectively in cancer cells by using the progression-elevated gene-3 promoter.

Authors:  Zhao-Zhong Su; Devanand Sarkar; Luni Emdad; Gregory J Duigou; Charles S H Young; Joy Ware; Aaron Randolph; Kristoffer Valerie; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-12       Impact factor: 11.205

4.  Radiation therapy potentiates effective oncolytic viral therapy in the treatment of lung cancer.

Authors:  Prasad S Adusumilli; Brendon M Stiles; Mei-Ki Chan; Ting-Chao Chou; Richard J Wong; Valerie W Rusch; Yuman Fong
Journal:  Ann Thorac Surg       Date:  2005-08       Impact factor: 4.330

5.  Phosphorylation at tyrosine 262 promotes GADD34 protein turnover.

Authors:  Wei Zhou; Krishna Jeyaraman; Permeen Yusoff; Shirish Shenolikar
Journal:  J Biol Chem       Date:  2013-10-03       Impact factor: 5.157

6.  An upstream open reading frame regulates translation of GADD34 during cellular stresses that induce eIF2alpha phosphorylation.

Authors:  Yun-Young Lee; Randal C Cevallos; Eric Jan
Journal:  J Biol Chem       Date:  2009-01-08       Impact factor: 5.157

Review 7.  Chapter One---Cancer terminator viruses and approaches for enhancing therapeutic outcomes.

Authors:  Swadesh K Das; Siddik Sarkar; Rupesh Dash; Paul Dent; Xiang-Yang Wang; Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2012       Impact factor: 6.242

8.  Gene expression analysis of the hepatotoxicant methapyrilene in primary rat hepatocytes: an interlaboratory study.

Authors:  Johanna M Beekman; Franziska Boess; Heinrich Hildebrand; Arno Kalkuhl; Laura Suter
Journal:  Environ Health Perspect       Date:  2006-01       Impact factor: 9.031

9.  Impact of α-targeted radiation therapy on gene expression in a pre-clinical model for disseminated peritoneal disease when combined with paclitaxel.

Authors:  Kwon Joong Yong; Diane E Milenic; Kwamena E Baidoo; Martin W Brechbiel
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

Review 10.  Cancer terminator viruses (CTV): A better solution for viral-based therapy of cancer.

Authors:  Luni Emdad; Swadesh K Das; Xiang-Yang Wang; Devanand Sarkar; Paul B Fisher
Journal:  J Cell Physiol       Date:  2018-02-27       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.